🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II trial to study the safety and efficacy of IMMU-130. IMMU...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT01915472
Treatments Being Tested
The purpose of this trial is to determine the safety of 90Y-hMN14 at differ...
Status
Completed
Location
Hoag Cancer Center
Start Date
2000-01
Trial ID
NCT00040599
Treatments Being Tested
This is a Phase I trial to study the safety of IMMU-130. IMMU-130 is compos...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2011-05
Trial ID
NCT01270698
Treatments Being Tested
The purpose of this trial is to determine the safety of hMN14 at different ...
Status
Completed
Location
Hoag Cancer Center
Start Date
2000-02
Trial ID
NCT00041652
Treatments Being Tested
The purpose of this trial is to determine the safety of 90Y-hMN14 at differ...
Status
Terminated
Location
Washington Hospital Center
Start Date
TBD
Trial ID
NCT00041691
Treatments Being Tested
The purpose of this trial is to determine the safety of 90Y-hMN14 at differ...
Status
Completed
Location
Hoag Cancer Center
Start Date
2000-01
Trial ID
NCT00041639
Treatments Being Tested
The goal of this clinical study is to determine the dosing and safety of la...
Status
Terminated
Location
UCLA Jonsson Comprehensive Cancer Center
Start Date
2013-02-12
Trial ID
NCT01605318
Treatments Being Tested